PMR Ltd, March 2011, Pages: 161
Pharmaceutical and healthcare market in Poland 2011 is PMR’s key report providing a comprehensive study of recent trends, developments and forecasts in the pharmaceutical and healthcare sector
PMR Ltd, March 2011, Pages: 161
Pharmaceutical and healthcare market in Poland 2011 is PMR’s key report providing a comprehensive study of recent trends, developments and forecasts in the pharmaceutical and healthcare sector
Decision Resources, Inc., June 2011
and developing economies of Asia Pacific and Latin America? Owing to their rapid growth, most pharmaceutical companies are focusing on the emerging markets of Brazil, Russia, India, China, Mexico, and Turkey (BRIC
Espicom Business Intelligence Ltd, June 2011
South Korea, Mexico, Turkey, Indonesia and Poland. In an environment which is becoming more regulated, pharmaceutical producers are re-aligning their global strategies.
Quality information = business
Espicom Business Intelligence Ltd, Feb 2012
South Korea, Mexico, Turkey, Indonesia and Poland. In an environment which is becoming more regulated, pharmaceutical producers are re-aligning their global strategies.
Quality information = business
Datamonitor, Jan 2011, Pages: 791
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
LEADING COMPANIES
MARKET FORECASTS
MACROECONOMIC INDICATORS
PHARMACEUTICALS IN POLAND
MARKET OVERVIEW
MARKET VALUE
MARKET SEGMENTATION I
Venn Research Inc., Aug 2010, Pages: 106
of the pharmaceutical sector by each country via-a-vis global market
- Market forecast of PolandPharmaceuticals market, by revenue till 2014.
- Covered more than 12 company profiles in the pharmaceutical sector
Business Monitor International, Oct 2010, Pages: 84
In Pharmaceuticals & Healthcare Business Environment Ratings for Q410, the Czech Republic has retained its top position and has extended its lead over second placed Poland. The long-term outlook
Global Industry Analysts, Inc., Jan 2011, Pages: 221
Outsourcing Emerges as a Strategic Priority for Pharmaceutical
Companies
Virtual Pharma vs. Blockbuster Model
Investment Risks in Pharmaceutical Contract
Quality Assurance Risk
Drug Development Risk
Business Monitor International, Jan 2012, Pages: 73
PolandPharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies
GBI Research, Dec 2011, Pages: 103
it difficult for pharmaceutical companies to extract a better Return on Investment (ROI) from their drugs as the cost of developing a single drug has increased exponentially.
Poland holds a strategic
Business Insights, May 2006, Pages: 199
eight of the accession countries including the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Slovakia and Slovenia (The A8).
“Pharmaceutical Growth Opportunities in the EU Accession
Business Monitor International, May 2010, Pages: 85
with independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry.
BMI’s Pharmaceuticals & Healthcare Business Environment Ratings for Q310 put Poland as the second most
Business Monitor International, May 2011, Pages: 98
with independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry.
Poland’s pharmaceutical market offers good prospects over the medium term combining high single digit
Global Industry Analysts, Inc., Sep 2008, Pages: 108
in € Billion for Years 2003 through 2008 66
6a. Denmark 67
Overview 67
6b. Germany 67
Healthcare System 67
SHI Modernization Act 67
6c. Italy 67
Overview 67
6d. Poland 68
Overview 68
6e
Business Monitor International, Nov 2010, Pages: 91
with independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry.
Poland is an important pharmaceutical market in Central and Eastern Europe (CEE), and is a relatively
Business Monitor International, Feb 2010, Pages: 82
and regulatory bodies with independent forecasts and competitive intelligence on Poland's pharmaceuticals and healthcare industry.
BMI considers Poland’s pharmaceutical market reasonably attractive
